PR NEWSWIRE

Previous Stories

University of Technology Sydney academic appointed to lead national climate plan for Australia’s business schools

Nov 08 2022 - PR NewsWire

SYDNEY, Nov. 8, 2022 /PRNewswire/ – Associate Professor Melissa Edwards of the University of Technology Sydney (UTS) Business School has been…


HOW HIGHER INTEREST RATES HAVE CAUSED A RIPPLE EFFECT WITHIN THE SYDNEY REMOVALISTS INDUSTRY, CITY REMOVALIST & STORAGE REVEAL WHY

Nov 08 2022 - PR NewsWire

SYDNEY, Nov. 8, 2022 /PRNewswire/ – As the Reserve Bank of Australia raises interest rates to fight inflation, the seventh rate…


Alterity Therapeutics Announces Presentation of Data from the bioMUSE Natural History Study at the American Autonomic Society Annual Meeting

Nov 08 2022 - PR NewsWire

MELBOURNE, Australia and SAN FRANCISCO, Nov. 7, 2022 /PRNewswire/ – Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a…


Axiom Acquires Plexus’s Flexible Legal Talent Division Plexus Engage

Nov 07 2022 - PR NewsWire

Acquisition Further Expands Axiom’s Global Reach Deal Allows Plexus to Focus on the Global Growth of its Technology Business MELBOURNE,…


Fat Tail Investment Research – Inflation, Bear Markets, and Recessions: What Should Investors Know

Nov 07 2022 - PR NewsWire

Investors Are Wondering How to Navigate This Bear Market MELBOURNE, Australia, Nov. 7, 2022 /PRNewswire/ — Financial publisher Fat Tail…


Herbalife Nutrition Survey: Unbalanced Diet, Physical Inactivity and Inadequate Sleep Among the Top Unhealthy Habits APAC Consumers Want to Kick in Next 12 Mont

Nov 07 2022 - PR NewsWire

Virtual Run by Herbalife Nutrition is back for the third year running to spur actions for building healthy active living…


PCI Security Standards Council Hires Yew Kuann Cheng Regional Vice President, Asia-Pacific

Nov 07 2022 - PR NewsWire

 Long time payment security expert to lead Asia-Pacific efforts for the PCI SSC  WAKEFIELD, Mass., Nov. 7, 2022 /PRNewswire/ —…


Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study

Nov 07 2022 - PR NewsWire

Summary of Study Outcomes ZIRCON Phase III study of Telix’s investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma…


Certa Therapeutics’ investigational drug FT011 delivers breakthrough results as a potential novel treatment for serious inflammatory and fibrotic diseases

Nov 04 2022 - PR NewsWire

Research presented today by University of Michigan Medical School highlights FT011’s ground-breaking treatment potential from human expression profiles in chronic…


NSW Health & Cicada Innovations celebrate Australia’s biggest health startup training program with 1.1k participants in first year

Nov 04 2022 - PR NewsWire

SYDNEY, Nov. 4, 2022 /PRNewswire/ – The NSW Health Commercialisation Training Program (CT Program), delivered by Australia’s pioneer deep tech incubator Cicada Innovations and…


Analyse The Market From A Different Angle